DISTRESSED DAILY: Healogics Is Hurting, and Pain May Get Worse

The vital signs for Healogics Inc. are weakening as the ailing wound-care company faces falling demand for its main product and a heavy debt load.

• Doubts about the effectiveness of its treatment have left its corporate entity, CDRH Parent Inc., at growing risk of restructuring in the next six months, according to areport by S&P Global Ratings.
  • Healogics “will be challenged to comply with its senior secured leverage covenant in 2020,” analysts Sarah Kahn and David Peknay wrote. Ebitda probably won’t cover the company’s interest expense and capital spending in 2019 and 2020, they said.
• At issue is hyperbaric ...